Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Supply Chain International Coronavirus COVID-19

IGBA Offers Input On WHO Pandemic Accord

Highlights Harmonization, IP, Regulatory Efficiency And Supply-Chain Sustainability

  • News

Executive Summary

As the WHO seeks input on a global accord to strengthen pandemic preparedness, the IGBA has provided suggestions from the off-patent industry ahead of a key step in the drafting process later this month.

You may also be interested in...



Biogen Gets First US Tocilizumab Biosimilar

Biogen has celebrated the approval by the US FDA of its Bio-Thera-partnered Tofidence biosimilar rival to Actemra. The firm said it was “currently evaluating the potential launch timeline.”

Fresenius And Formycon File Ustekinumab In Europe

Fresenius Kabi and Formycon have seen their filing for an ustekinumab biosimilar rival to Stelara accepted for review by the European Medicines Agency. A filing with the US FDA is also on the way.

Shortlist Revealed Ahead Of October Awards

Ahead of the Global Generics & Biosimilars Awards, which are this year being held on Wednesday 25 October at the Hotel Porta Fira in Barcelona, we reveal our final shortlist of entrants across all 14 categories.

Table

View full table

Topics

Tags:
Supply Chain International Coronavirus COVID-19
Latest Headlines

Novo Files Suit Over IRA As It Joins Others In Signing On To Price Negotiations

IRA Litigation Hurdles Clarified With Ruling In Chamber Of Commerce Suit

Japan Approves Leqembi, All Eyes Now On Extended Pricing Discussions

EU’s Unitary SPC System Must Maximize Access To Medicines & Not Block Generic Entry

See All
UsernamePublicRestriction

Register

GB152693

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By